Training & Events
CAPD/ACPD Annual Session
This lecture with hands-on workshop will provide a basis of knowledge for new materials for pulp therapy and cementation.
• Review traditional and bioactive materials for primary and young permanent teeth.
• Understand the properties and benefits of bioactive cements.
• Demonstrate competency in mixing/placement of MTA for Pulpotomy and Indirect Pulp Capping.
• Ensure successful cementation of Zirconia Crowns.
$195 USD | 2CE
and includes a 1gm kit of NuSmile NeoMTA as well as a 2.5mL Syringe of NuSmile BioCem cement.
Thursday, September 14th
5:30-7:30pm Lecture and hands-on workshop
7:30-8:30pm NuSmile CAPD/ACDP kick-off reception
SVP New product developement | NuSmile
Mark Binford has a Chemical Engineering degree from Univ. of Texas –Austin, he is a co-author of two US patents for the chemical applications of material in the oil and gas processing. His experience in business development, marketing, and sales has included medical device manufacturing, engineered software applications and specialty chemicals for large publicly held corporations including Symantec, BMC Software, Betz Laboratories and Citgo. Mr. Binford is currently Senior Vice President for new product development at NuSmile in Houston, Texas where he recently lead the development and marketing of their new bioactive cement, BioCem. Mr. Binford is well informed about the challenges in the clinical practice of pediatric dentistry as he attends many of the national and international dental conventions representing NuSmile.
Full-time university faculty and residents contact Nikki Ruck to register at 713.568.1023 or firstname.lastname@example.org
The Institute for Pediatric Dentistry is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by the AGD for Fellowship/Mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from 11/1/2016 to 10/31/2018 – Provider ID#372779